ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Doxiproct® Plus:OM Pharma SA
Vollst. FachinformationDDDDrucken 
Gal.Form/Ther.Gr.Zusammens.Eigensch.Pharm.kinetikInd./Anw.mögl.Dos./Anw.Anw.einschr.Unerw.Wirkungen
Interakt.Überdos.Sonstige H.Swissmedic-Nr.Stand d. Info. 
C05AA09 - DexamethasoneATC-DDD Version 2016. Source: WHO
C - Cardiovascular System

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.

C05 - Vasoprotectives
 

No DDDs are established in this group, since most of the drugs in this group are for topical use.

C05A - Agents for Treatment Of Hemorrhoids and Anal Fissures for Topical Use

This group comprises agents for local use, such as suppositories, ointments etc. Preparations used for treatment of perineal trauma are classified here.

C05AA - Corticosteroids

All antihemorrhoidal products, which contain corticosteroids, are classified in this group, including both plain products and combinations with antiinfectives, local anesthetics etc. At each 5th plain level, combinations may occur.

C05AA09 - Dexamethasone
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home